American Capital Management’s Integra LifeSciences IART Stock Holding History

American Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-26,014	Closed	-$775K	–	109
2015 Q3	$775K	Buy	26,014 +8,889	+52%	+$278K	0.08%	62
2015 Q2	$472K	Hold	17,125	–	–	0.05%	66
2015 Q1	$432K	Hold	17,125	–	–	0.04%	66
2014 Q4	$380K	Sell	17,125 -85,627	-83%	-$1.74M	0.04%	70
2014 Q3	$2.08M	Hold	102,752	–	–	0.24%	54
2014 Q2	$1.98M	Hold	102,752	–	–	0.22%	55
2014 Q1	$1.93M	Hold	102,752	–	–	0.23%	57
2013 Q4	$2M	Hold	102,752	–	–	0.25%	56
2013 Q3	$1.69M	Hold	102,752	–	–	0.23%	61
2013 Q2	$1.54M	Buy	+102,752	New	+$1.51M	0.23%	63

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

American Capital Management's IART Position: Q4 2015 in Review

American Capital Management sold out of Integra LifeSciences (IART) in Q4 2015, closing a stake of 26,014 shares — an estimated $775K sold.

American Capital Management first reported a position in IART in Q2 2013 and held it in 10 quarters. The position peaked at $2.08M in Q3 2014. 187 funds tracked by Wall St. Rank hold IART as of Q4 2015.

American Capital Management reported no remaining Integra LifeSciences position as of Q4 2015 after selling out during the quarter.
American Capital Management sold 26,014 Integra LifeSciences shares in Q4 2015, an estimated $775K.
American Capital Management first reported a position in Integra LifeSciences in Q2 2013 and held it in 10 quarters.
American Capital Management's Integra LifeSciences position peaked at $2.08M in Q3 2014.
187 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2015.

Based on American Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.